INS and diabetes mellitus: This further supports the idea that inhibition of PKR by IHZ could alleviate diabetes induced, metabolic impairments and inflammation and fibrosis in the insulin sensitive organs and tissues, such as skeletal muscles, adipose tissue, pancreas, and liver of the diabetic patients.